Home/Pipeline/BioWavePENS

BioWavePENS

Severe Pain (e.g., from injury)

CommercialActive

Key Facts

Indication
Severe Pain (e.g., from injury)
Phase
Commercial
Status
Active
Company

About BioWave

BioWave is a commercial-stage medical device company focused on non-invasive, high-frequency peripheral nerve stimulation for pain relief. Its core technology differentiates from superficial TENS units by delivering stimulation deep to the nerve to block pain signal transmission, offering hours of relief post-treatment. With multiple FDA-cleared products (BioWavePRO, HOME, GO, PENS) and a significant contract with the US Veterans Administration, the company targets the large chronic and acute pain markets, emphasizing drug-free alternatives. BioWave operates as a private company, generating revenue through device sales to providers, patients, and institutional partners.

View full company profile

Therapeutic Areas